Categories
Health

FDA Approves Fourth Denosumab Biosimilar

Source link : https://newshealth.biz/health-news/fda-approves-fourth-denosumab-biosimilar/

The US Food and Drug Administration (FDA) has approved denosumab-bnht (Conexxence/Bomyntra), manufactured by Fresenius Kabi, for all indications of the reference product denosumab (Prolia/Xgeva). The biosimilar will launch in the United States in June 2025 as part of a global settlement with Amgen, which manufactures the reference product.  The higher dosage of denosumab-bnht (Bomyntra; 120 […]

The post FDA Approves Fourth Denosumab Biosimilar first appeared on News Health.

Author : News Health

Publish date : 2025-03-28 08:00:00

Copyright for syndicated content belongs to the linked Source.

.. . . . . . . . . . . . . . . . . . . . . . . . . ***. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ - - - - - - - - - - - - - - - - - - - - . . . . .